MX2021012375A - Metodo para tratar y prevenir infecciones oseas y de articulaciones. - Google Patents
Metodo para tratar y prevenir infecciones oseas y de articulaciones.Info
- Publication number
- MX2021012375A MX2021012375A MX2021012375A MX2021012375A MX2021012375A MX 2021012375 A MX2021012375 A MX 2021012375A MX 2021012375 A MX2021012375 A MX 2021012375A MX 2021012375 A MX2021012375 A MX 2021012375A MX 2021012375 A MX2021012375 A MX 2021012375A
- Authority
- MX
- Mexico
- Prior art keywords
- gram
- treating
- bone
- preventing
- seq
- Prior art date
Links
- 206010005940 Bone and joint infections Diseases 0.000 title 1
- 206010060968 Arthritis infective Diseases 0.000 abstract 2
- 241000192125 Firmicutes Species 0.000 abstract 2
- 206010031252 Osteomyelitis Diseases 0.000 abstract 2
- 241000191963 Staphylococcus epidermidis Species 0.000 abstract 2
- 210000000988 bone and bone Anatomy 0.000 abstract 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 241000191967 Staphylococcus aureus Species 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000003385 bacteriostatic effect Effects 0.000 abstract 1
- 210000001179 synovial fluid Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Surgery (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962832754P | 2019-04-11 | 2019-04-11 | |
| US201962849672P | 2019-05-17 | 2019-05-17 | |
| US201962938812P | 2019-11-21 | 2019-11-21 | |
| US202062964755P | 2020-01-23 | 2020-01-23 | |
| PCT/US2020/027752 WO2020210691A1 (en) | 2019-04-11 | 2020-04-10 | Method of treating and preventing bone and joint infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021012375A true MX2021012375A (es) | 2021-11-17 |
Family
ID=72752118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021012375A MX2021012375A (es) | 2019-04-11 | 2020-04-10 | Metodo para tratar y prevenir infecciones oseas y de articulaciones. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220193186A1 (https=) |
| EP (1) | EP3980049A4 (https=) |
| JP (1) | JP2022526624A (https=) |
| KR (1) | KR20210151188A (https=) |
| CN (1) | CN114025783A (https=) |
| AU (1) | AU2020271116A1 (https=) |
| BR (1) | BR112021019884A2 (https=) |
| CA (1) | CA3136461A1 (https=) |
| IL (1) | IL286994A (https=) |
| MX (1) | MX2021012375A (https=) |
| WO (1) | WO2020210691A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023081691A1 (en) * | 2021-11-04 | 2023-05-11 | Contrafect Corporation | Method of treating and preventing bone and joint infections |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2833409A1 (en) * | 2011-04-21 | 2012-10-26 | The Rockefeller University | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria |
| KR20210121313A (ko) * | 2012-05-09 | 2021-10-07 | 콘트라펙트 코포레이션 | 그람 양성 박테리아에 대한 박테리오파지 리신과 항생제의 병용물 |
| KR20200023521A (ko) * | 2012-05-09 | 2020-03-04 | 콘트라펙트 코포레이션 | 박테리오파지 리신을 이용한 생물막의 예방, 붕괴 및 치료 |
| KR20190004799A (ko) * | 2016-05-12 | 2019-01-14 | 콘트라펙트 코포레이션 | 항균 폴리펩티드의 최소 억제 농도를 평가 및 탐지하기 위한 배지미량희석법 |
| KR20200124724A (ko) * | 2018-02-26 | 2020-11-03 | 콘트라펙트 코포레이션 | 변형된 PlySs2 리신 및 이의 용도 |
| CN112867398A (zh) * | 2018-06-22 | 2021-05-28 | 康特拉费克特公司 | 溶素及其衍生物使金黄色葡萄球菌和革兰氏阳性菌对抗生素重新敏感 |
-
2020
- 2020-04-10 EP EP20788204.4A patent/EP3980049A4/en not_active Withdrawn
- 2020-04-10 JP JP2021559424A patent/JP2022526624A/ja active Pending
- 2020-04-10 CA CA3136461A patent/CA3136461A1/en active Pending
- 2020-04-10 MX MX2021012375A patent/MX2021012375A/es unknown
- 2020-04-10 CN CN202080042979.2A patent/CN114025783A/zh active Pending
- 2020-04-10 KR KR1020217036829A patent/KR20210151188A/ko active Pending
- 2020-04-10 US US17/602,064 patent/US20220193186A1/en not_active Abandoned
- 2020-04-10 AU AU2020271116A patent/AU2020271116A1/en not_active Abandoned
- 2020-04-10 WO PCT/US2020/027752 patent/WO2020210691A1/en not_active Ceased
- 2020-04-10 BR BR112021019884A patent/BR112021019884A2/pt not_active IP Right Cessation
-
2021
- 2021-10-05 IL IL286994A patent/IL286994A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3136461A1 (en) | 2020-10-15 |
| WO2020210691A1 (en) | 2020-10-15 |
| AU2020271116A1 (en) | 2021-11-11 |
| BR112021019884A2 (pt) | 2022-01-18 |
| KR20210151188A (ko) | 2021-12-13 |
| IL286994A (en) | 2021-12-01 |
| JP2022526624A (ja) | 2022-05-25 |
| EP3980049A4 (en) | 2023-07-19 |
| US20220193186A1 (en) | 2022-06-23 |
| EP3980049A1 (en) | 2022-04-13 |
| CN114025783A (zh) | 2022-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014149348A (ru) | Предотвращение, разрушение и обработка биопленки лизином бактериофага | |
| RU2018107249A (ru) | Применение лизина для восстановления/увеличения антибактериальной активности антибиотиков в присутствии легочного сурфактанта, который ингибирует указанные антибиотики | |
| PH12020550107A1 (en) | Chromane monobactam compounds for the treatment of bacterial infections | |
| RU2014149351A (ru) | Комбинации лизина бактериофага и антибиотика против грам-положительных бактерий | |
| WO2009111064A3 (en) | Minocycline compounds and methods of use thereof | |
| HRP20131170T1 (hr) | Nova antibakterijska sredstva za lijeäśenje gram-pozitivnih infekcija | |
| MX2021003084A (es) | Compuestos antibacterianos. | |
| WO2018155813A3 (ko) | 엔테로코쿠스 패슘에 대하여 용균력을 가지는 신규한 항균단백질 efal-2 | |
| JP2013539776A5 (https=) | ||
| MX2021001564A (es) | Diazabiciclooctanonas como inhibidores de serina beta-lactamasas. | |
| WO2020102901A8 (en) | Synthetic antibacterial compounds and uses thereof | |
| PH12021553086A1 (en) | Medicament and use thereof for treating bacterial infections involving biofilm | |
| PH12021552875A1 (en) | METHODS AND COMPOSITIONS COMPRISING STAPHYLOCOCCUS PROTEIN A (SpA) VARIANTS | |
| JP2017533177A5 (https=) | ||
| WO2010041970A3 (en) | Antibacterial phage peptides and methods of use thereof | |
| HRP20200195T1 (hr) | Antibiotske terapije na bazi peptida porijeklom od vodenog bivola | |
| CA3010564A1 (en) | An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition | |
| CR20230510A (es) | Compuestos de lactivicina, su preparación y uso como agentes antibacterianos | |
| MX2021012375A (es) | Metodo para tratar y prevenir infecciones oseas y de articulaciones. | |
| WO2013041663A3 (de) | Modifizierte apidaecinderivate als antibiotische peptide | |
| WO2019222502A8 (en) | Endolysins active against bacillus bacteria, pharmaceutical compositions, and methods relating thereto | |
| WO2009124086A3 (en) | Antibacterial drug for treatment of staphylococcus aureus and other gram-positive bacterial infections | |
| MX2021011469A (es) | Combinacion de lisina(s) y antibiotico(s) para tratar o prevenir endocarditis infecciosa debida a bacterias gram-positivas. | |
| WO2019186387A3 (en) | Novel heterocyclic systems and pharmaceutical applications thereof | |
| SA121420507B1 (ar) | طريقة لعلاج عدوى بكتيرية باستخدام اللبأ |